logo
Gen Z and spirits: a golden opportunity?

Gen Z and spirits: a golden opportunity?

Yahoo04-07-2025
Research aplenty has emerged to support the idea that Gen Z drinkers – those of legal drinking age born between 1997 and 2012 – are moving away from alcohol. Yet recent analysis and industry players are seeking to dispel the argument.
Earlier this year, Rabobank analyst Bourcard Nesin highlighted multiple factors were causing reduced spending by Gen Z on alcohol, including the cohort's lower incomes, is more diverse and made up of demographic groups that historically don't drink as much.
When it comes to Gen Z consumption of specific products, like spirits, data is harder to come by, though major distillers are generally confident they are able to win over younger drinkers.
Speaking at a Diageo event in June, Giles Hedger, the group's global consumer planning director, said its research found Gen Z consumers 'drink socially a little less frequently than other cohorts" but he added: 'They do so very enthusiastically and in a very socially anchored way."
Hedger was confident that, as a spirits-led business, Diageo was in a good position. 'We will experience Gen Z differently,' he said. 'We're a spirits-focused business, Gen Z love spirits. We're an innovation-focused business, Gen Z love experimentation and exploration.'
Findings from GlobalData, Just Drinks' parent, suggest spirits are more likely to succeed with younger legal-age drinkers compared to other alcoholic drinks. The data analytics group found Gen Z tends to be 'underrepresented in traditional, high-volume categories' like beer but are 'more likely to be over-represented in spirit-based RTDs, cocktails, liqueurs, and aperitifs'.
Spirits may indeed chime well with Gen Z compared to other alcohol products but what are their preferred serves? Where are they drinking? What can they spend and is developing a targeted approach the right answer for distillers?
According to GlobalData, Gen Z drinkers are moving away from 'mainstream volume'-led alcoholic drinks, such as beers.
In survey carried out by the data analytics company last year, 59% of respondents said they were 'more loyal to brands that offer a personalised product/service', while 57% noted they would be more likely to buy from brands that offer personalised products/services'. One spirits-based drink aligning with these qualities is cocktails.
'There's a lot of interest in cocktails' among Gen Z drinkers, David Harris, alcoholic beverages director at GlobalData tells Just Drinks. 'There's a lot of interest in mocktails, as well as semi-cocktails, or long drinks. If they come in a can, there's a lot of interest in that. Hard seltzers did very well to benefit from this as well in an adjacent space.'
Harris says globally, 'on a very granular level', there's a 'move towards fruitier flavours, which, again, is very much met by the approach of cocktails'. Consumers in Africa and Latin America are displaying a greater interest in 'fruit-driven or sweeter flavours".
He adds: "Particularly in Africa, more so than anywhere else, there's a real push back against what their dad's drank."
In Western countries, there is not so much a focus on fruity flavours but more 'the brand heritage angle', Harris says, which he argues benefits products like Bourbon and Tequila.
Harris doesn't classify gin as 'one of the big losers' but believes it has 'fallen out of fashion… as its own thing' from the growth it experienced with millennial drinkers. Vodka meanwhile is holding steady, he adds. 'It's kind of a bit timeless. It's not seeing a massive growth outside of fruit-flavoured vodka, but nor has it fallen out of favour.'
According to Hedger, Diageo's research has found Gen Z are mainly showing interest in three spirits – Tequila, vodka and gin. All three are segments in which the company has a leading presence globally. Hedger did not disclose which spirits were some of the least popular.
What spirits click with Gen Z also depends on local factors, says Jing Mertoglu, global vice president for insights, analytics, innovation and marketing at Suntory Global Spirits.
'In India, whisk(e)y is a common spirit that people partake with, even when they're younger and LDA. So, whisky, meaning Scotch, [it's] not as scary as it is with other markets.'
Some markets like Korea and China also have spirits which 'are very traditional and endemic to the culture', she says, like soju and baijiu.
While these spirits have strong geographical ties, Mertoglu says there still is opportunity for foreign spirits, like American whiskey, which 'is continuing to attract a lot of younger cohorts as well, and [regions] outside of the traditional markets, like Germany, Australia, the United States'.
Spirits-based ready-to-drink products also have particular promise with younger drinkers, many of which will be fairly new to spirits.
'Spirits is a huge opportunity when intertwined with RTD, and it's proven very well in terms of growth rates,' explains Suntory's Mertoglu. She argues they deliver 'flavour and experience' and 'potential ways to discover new drinks'.
The US, Australia and Germany are 'strongholds' for Suntory's RTDs range, as well as China and Taiwan where the group sells its Minus 196 vodka seltzers.
Earlier this year, Diageo launched Muck Pit – a sparkling tropical brew made with brewed mangoes, Captain Morgan's Spiced Gold rum and hop flavourings – in the UK. The company will eventually roll-out the product to Europe, Africa and Asia.
Nathan McGivern, innovation marketing manager for Diageo's Baileys brand in Europe (and formerly for cocktails) said the company found younger drinkers are resonating most with craft beer brands but they don't necessarily find them easy to drink. The Captain Morgan Muck Pit Brew product looks to offer similar hoppy notes to beer, served in a pint glass, but with a sweeter, tropical flavour. Will blurring the lines between spirits and beer appeal to Gen Z? Diageo will have to wait out the testing phase to see.
With Gen Z being a low-income cohort, it may be surprising that some players see an opportunity in targeting younger drinkers with more expensive products.
Diageo, which sells its "luxury" products at $100 and above is one such company.
While the segment 'is not uniquely or specifically a Gen Z opportunity', Hedger says, 'it does link to Gen Z' and 'younger cohorts, because, to coin a phrase, 'luxury is getting younger'.'
According to Hedger, the next ten years will see millennials and Gen Zers making up '75% of all of the luxury personal goods buyers on Earth'.
It's unrealistic to assume young people will start forking out their savings on a four-digit sum on a rare edition of Johnnie Walker but it doesn't mean they don't want a taste of more upmarket products. Younger drinkers have an 'aspiration to have a small part of a so-called luxury lifestyle', according to Hedger.
'Our business focuses on everyday luxuries and so we become part of that. We are an achievable luxury. We're within reach for many people.'
GlobalData's Harris also sees opportunity for pricier spirits with Gen Z drinkers but that it lies more within the on-trade.
'In the on-trade, they want not just a cocktail. They want a cocktail with the individual brands broken out,' says Harris, adding growing numbers of bars have started including the name of the spirits brands on menus.
Our business focuses on everyday luxuries, and so we become part of that. We are an achievable luxury. We're within reach for many people Giles Hedger, global consumer planning director, Diageo
In retail on the other hand, younger drinkers are more likely to be purchasing 'mass premium' labels, Harris says.
'We also see them far more financially sensible than millennials or Gen Xs were at this stage of their lives. They will not part of that sort of cash. What they would do is probably spend £30/£40 ($41/$55) on an upper level but not explicitly luxury bottle.'
While there are opportunities to sell luxury spirits to Gen Z, products need to be within their financial reach.
As Laurence Whyatt, head of European beverages research at Barclays, says: 'Affordability is a clear issue at the moment, just on the back of the levels of inflation that we've seen over the past few years and the higher interest rates, so any sort of loan payment is going to be impacting discretionary income.'
A GlobalData survey carried out last year showed some 21% said they spent a 'medium' amount on spirits more broadly. Meanwhile, 8% and 12% said they had a 'very high' and 'quite high' spend on spirits, while 13% and 15% reported spending a 'very low' and "quite low" amount respectively.
As Harris notes, though Gen Z are showing interest in mixed and longer spirits-based drinks, they are buying fewer of them. 'The competing challenge of that is Gen Z is don't have much money but facing really tough financial times', he says. 'What we're seeing in practice is that they are buying these cocktails, of these long drinks, but for only drinking one or two'.
This doesn't mean producers shouldn't sell high-end products to Gen Z, they just need to remain accessible. One way companies are doing this is through smaller pack formats. For example, Diageo's 5cl miniature of Don Julio 1942, is sold around the world. In the UK, the product retails between £16.50-£20 a bottle.
As Barclays' Wyatt explains: 'You might not be able to afford a 75cl bottle but you could afford a 325ml or even a 50ml".
'Let's say you were going to a dinner party. If you bought a bottle of 1942 that's going to cost you $200. If you wanted little miniatures, you could say [have] two couples having dinner, four miniatures of [Don Julio] 1942 even two miniatures of 1942, you share them. It's a much more affordable way of having the same experience.'
Though it will take a lot of purchases to provide the same value and volumes, smaller packs can open up more expensive brands to a generation with less cash on hand.
'Perhaps you increase regular spend, but historically, people only buy six bottles of spirits a year, that's the average in the US,' adds Wyatt. 'So, if you're just doing it more frequently, then you align with people's pay packet timing, and you keep people in the category.'
Knowing what types of spirits Gen Z enjoy is key to securing their consumption but producers also need to know where they are most likely to buy their drinks.
Hedger at Diageo believes the generation is 'over indexing' towards the on-trade.
Harris agrees, noting that while the Covid-19 pandemic meant Gen Z could not visit bars as often as previous generations, they have been consuming in on-trade spaces but with 'a far more measured kind of approach'.
Social occasions no longer tend to be directly associated with alcohol by this cohort, meaning general alcohol consumption at-home and in the on-trade has been affected, Harris adds. 'But if they are drinking alcoholic beverages, it is far more likely to be in the on-trade."
Hedger also stresses the importance for 'the outdoors and the third spaces' like festivals, meaning 'they bring with them a kind of strong indicator for convenience.'
Music festivals have played a key role in building brand recognition for Absolut vodka, says Mathieu Deslandes, global innovation director at Pernod Ricard.
'From a festival point of view, the brand has been connecting to Coachella Festival for multiple years by being present where Gen Z is present, whether it's within the festival industry, whether it's the artistic aspect and bringing that creativity.'
He adds: 'We know that Gen Z, like any young generation, are probably always more open to creativity and self-expression.'
Is it necessary to develop tailored products and marketing towards Gen Z? Given the changing nature of consumer tastes, some companies prefer to focus on a broad audience as opposed to a single cohort.
'It would be wrong to be obsessed by just one target group,' Deslandes tells Just Drinks. 'One target group [that is] in an evolution… maybe next year, or in two years' time or three years' time, [could be] slightly different.
'There is more change between 18 to 25 in terms of behaviour than between 30 and 80. That's why, yes, we are looking at market opportunities but, again, from a whole perspective, if we want to win in the future, we need to concentrate on where we can get more scale.'
One example of a broader focus is Pernod's Malibu white rum liqueur, which is marketed to younger drinkers but not exclusively.
It would be wrong to be obsessed by just one target group Mathieu Deslandes, global innovation director, Pernod Ricard
'What is more important to me for this brand is that it's a young mindset, rather than a young target,' Deslandes says. 'It doesn't stop you being 40 and wanting to have the fun of summer. Malibu is about celebrating summer and that summer mindset. I would say that whether you are young or not that summer mindset resonates [with] consumers.'
Deslandes adds consumers 'will probably connect to the Pernod Ricard portfolio slightly at a later stage of [their] life cycle because that level of sophistication and clearness and substance is more what you're looking for'. The older you get, 'the more you go premium' as buying power increases.
It's a point that was echoed by Rabobank's Nesin in his research. While alcoholic consumption may be lower now for Gen Z than previous generations at a similar age, he says Rabobank thinks it's likely 'by their mid-30s, their consumption will be much closer to that of previous generations".
That's 'an ideal outcome', Nesin says. But while it's always a good thing to adapt and learn how to serve a broad range of consumers, longer-term perhaps Gen Z won't stray too far from the path of previous generations as we might think.
"Gen Z and spirits: a golden opportunity?" was originally created and published by Just Drinks, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Keysight Technologies Inc (KEYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and AI ...
Keysight Technologies Inc (KEYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and AI ...

Yahoo

time26 minutes ago

  • Yahoo

Keysight Technologies Inc (KEYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and AI ...

This article first appeared on GuruFocus. Revenue: $1.4 billion, up 11% year-over-year. Earnings Per Share (EPS): $1.72, exceeding guidance. Orders: Increased by 7% year-over-year. Gross Margin: 64%. Operating Expenses: $526 million. Operating Margin: 25%, up 60 basis points from last year. Net Income: $297 million. Communications Solutions Group Revenue: $940 million, up 11% year-over-year. Electronic Industrial Solutions Group Revenue: $412 million, up 11% year-over-year. Cash Flow from Operations: $322 million. Free Cash Flow: $291 million. Cash and Cash Equivalents: $2.636 billion. Share Repurchase: 300,000 shares at an average price of $164, totaling $50 million. Q4 Revenue Guidance: $1.370 billion to $1.390 billion. Q4 EPS Guidance: $1.79 to $1.85. Warning! GuruFocus has detected 6 Warning Signs with VVOS. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Keysight Technologies Inc (NYSE:KEYS) reported an 11% year-over-year increase in revenue to $1.4 billion, exceeding the high end of their guidance. Orders increased by 7% with growth across both the Communications Solutions Group (CSG) and Electronic Industrial Solutions Group (EISG) segments. The company saw strong growth in aerospace, defense, government, and general electronics, with stability in wireless and automotive sectors. Keysight Technologies Inc (NYSE:KEYS) is capitalizing on AI momentum, with significant investments in AI-related technologies and partnerships, such as with AMD for PCIe Gen 6 compliance validation. The company reported a gross margin of 64% and an operating margin of 25%, with earnings per share of $1.72, up 9% year over year. Negative Points The company is facing challenges with tariffs, which are expected to increase their tariff exposure by approximately $75 million annually. Despite strong performance, the automotive sector remains stable year over year, indicating potential challenges in achieving growth in this segment. The broader 6G commercialization is still years away, which may delay potential revenue from this technology. The company is experiencing headwinds in the semiconductor sector, despite robust demand for wafer test solutions. There are ongoing geopolitical and macroeconomic uncertainties that could impact future performance and market conditions. Q & A Highlights Q: Satish, on past calls, you characterized your expectation for a recovery in the end markets overall as gradual. I don't think I heard you use that word today. Can you help investors understand your view of the end markets now and to what extent it's better than you'd previously expected? A: Strong quarter, clearly, and we're feeling good about the funnel and customer activity despite the overhang from tariffs and geopolitical environment. Order growth has accelerated, and we're feeling slightly better than expected at the beginning of the year. However, not all end markets are up; AI and aerospace defense are strong, while automotive faces challenges. Q: Can you help us better understand what's supporting the revenue outlook into 4Q, given that orders were up high-single digits but the book-to-bill was just below 1? A: Some of this is due to the timing of big deals. We had a large system integration deal accepted on the last day of Q3, which elevated Q3 performance and pulled from Q4. We expect more normal sequential seasonality on the order front than on the revenue front due to the timing of these deals. Q: Neil, as we think about revenue growth and recovery, you mentioned a 5% to 7% top-line growth rate as a long-term model. Is that how we should think about fiscal '26? A: We started the year with a gradual recovery expectation and are now looking at revenue growth at the low end of that range. Things have unfolded slightly better, allowing us to raise expectations. We're bullish going into '26, with caution around tariffs and macroeconomic factors. Q: How do you respond to investors asking about the mix of AI's contribution to the Keysight story, particularly in wireline? A: We're well-positioned for the long-term AI opportunity. AI will contribute across multiple end markets over time. Wireline business is expected to finish strong due to AI demand. It's hard to isolate AI's impact as it involves entrenched ecosystems, but business with us is growing, driven by AI. Q: Can you outline where the tariffs are most substantial for you, and is the mitigation plan focused on moving production or pricing? A: We have a geographically diverse manufacturing footprint, with significant operations in Southeast Asia, the EU, Japan, and the US. Mitigation involves supply chain strategies, possibly shifting manufacturing, and passing costs to customers through price increases and surcharges. We expect to fully mitigate the April tariffs by Q1 and the August increase by the first half of FY26. Q: On aerospace and defense, should we see this market continue to accelerate, or is this a good level due to the time it takes for programs to get into place? A: The starting point for the year was slower, but demand has returned in the second half. Ongoing programs and backlog for prime contractors are robust, indicating a positive environment. The US situation is understood, and European spending could impact long-term growth. Aerospace and defense are steady value creators, though growth may not be as quick as commercial markets. Q: Could you touch on the moving parts around the incremental margin of 40% you talked about? A: The 40% incremental margin is the right long-term target. Tariffs impacted this year's ability to deliver, but once included in the baseline, we can achieve it with mid-single-digit growth. Stripping out tariff impact, we are overachieving the 40% incremental in recent quarters. Q: Can you provide thoughts on customer engagement timelines and when 6G might become a more meaningful revenue contributor? A: Recent 3GPP meetings reinforced industry alignment from 5G to 6G, which is positive for us. Customers are exploring 6G facets, building IP for eventual rollout. While years away from rollout, R&D activity will grow, and we're well-positioned to support this transition. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...
Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...

Yahoo

time26 minutes ago

  • Yahoo

Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...

This article first appeared on GuruFocus. Total Revenue (H1 2025): $3.2 million, up from $2.3 million in H1 2024. Research and Development Expenses (H1 2025): $4.8 million, down from $6.5 million in H1 2024. Sales and Marketing Expenses (H1 2025): $800,000, down from $1.1 million in H1 2024. Total Operating Expenses (H1 2025): $7.7 million, down from $11.1 million in H1 2024. Cash and Short-term Bank Deposits (End of H1 2025): $11.7 million. Operating Loss (H1 2025): $6.1 million, down from $9.4 million in H1 2024. Net Loss (H1 2025): $7.7 million, down from $9.8 million in H1 2024. Cash Usage (Q2 2025): $2.4 million. Financing Income (H1 2025): $732,000, up from $373,000 in H1 2024. Loss from Operations Held for Sale, Net (H1 2025): $2.2 million, up from $0.8 million in H1 2024. Warning! GuruFocus has detected 6 Warning Signs with EVGN. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Evogene Ltd (NASDAQ:EVGN) reported an increase in total revenues for the first half of 2025 to approximately $3.2 million, up from $2.3 million in the first half of 2024, driven by strong seed sales from its subsidiary Casterra. The company executed a cost reduction plan, resulting in a significant decrease in operating expenses, with total operating expenses net for the first half of 2025 at approximately $7.7 million compared to $11.1 million in the same period last year. Evogene Ltd (NASDAQ:EVGN) completed the sale of Lavie Bio's assets and the MicroBoost AI for Ag tech-engine to ICL, generating significant cash flow and enhancing the company's financial position. The company is focusing on maximizing the value of its ChemPass AI platform, which has been strengthened by the completion of the GeneRator AI foundation model developed in collaboration with Google Cloud. Evogene Ltd (NASDAQ:EVGN) successfully raised $4.4 million through its ATM facility, providing a solid financial foundation and operational runway of approximately 18 months. Negative Points Evogene Ltd (NASDAQ:EVGN) is undergoing a strategic shift, which includes significant organizational changes and workforce reductions, potentially impacting employee morale and operational stability. The company reported a net loss for the first half of 2025 of approximately $7.7 million, although this was a decrease from the $9.8 million loss in the same period last year. There is uncertainty regarding the commercialization of Casterra's castor seed inventory, as the company is exploring options to sell seeds directly or grow and sell grain. The ongoing geopolitical situation in Israel, including the conflict with Hamas and Hezbollah, poses risks and uncertainties that could affect the company's operations and financial performance. Evogene Ltd (NASDAQ:EVGN) faces challenges in achieving peak sales and establishing new partnerships, particularly in the pharma and agriculture sectors, which are crucial for future growth. Q & A Highlights Q: How much castor seed inventory does Evogene have, and what are the plans if the current customer does not place a follow-on order? A: Ofer Haviv, President and CEO, stated that while he won't disclose specific inventory amounts, Evogene has a few hundred tons of Casterra seed ready for sale. The company plans to sell these seeds to partners or use them to grow grain through subcontractors, as they have a better understanding of cultivation in certain territories. Initial results from trials in Brazil and Kenya are promising. Q: What steps need to occur before Evogene can announce a castor oil business? A: Ofer Haviv explained that Evogene is currently focused on grain cultivation and selling grain to partners. There is significant demand from oil factories in Africa and Brazil. The main challenge is the cost of growing castor, which Evogene aims to address with its unique variety and growth protocols. Q: The stock is still low. When will it start going up? A: Ofer Haviv mentioned that while the stock market is unpredictable, Evogene is finalizing a new company presentation and website to reflect its strategy. The company plans to announce new collaborations in pharma and agriculture, which should strengthen its value proposition and potentially impact the stock positively. Q: How representative are operating expenses in Q2 2025, and are all cost reductions fully reflected? A: Ofer Haviv confirmed that the third and fourth quarters are expected to show continued declines in expenses across R&D, marketing, and G&A, reflecting the full impact of cost reductions. Q: What was revenue in Q2 '25, and how should we think about peak sales? A: Ofer Haviv noted that Casterra is currently the only activity producing regular sales, primarily from seed sales. The company is in discussions with multiple partners to expand castor oil activities, focusing on reducing cultivation costs to maximize yield versus expenses. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Sign in to access your portfolio

Medtronic PLC (MDT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance
Medtronic PLC (MDT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance

Yahoo

time26 minutes ago

  • Yahoo

Medtronic PLC (MDT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance

This article first appeared on GuruFocus. Revenue: $8.6 billion, grew 8.4% reported and 4.8% organic. Cardiovascular Growth: 7% growth, driven by nearly 50% growth in cardiac ablation solutions. Neuroscience Growth: 3% growth, with mid-single-digit growth in cranial and spinal technologies. Medsurge Growth: 2% growth, with high single-digit growth in advanced energy. Diabetes Growth: 8% growth, including 11% growth in international markets. Adjusted Gross Margin: 65.1%, down 80 basis points year over year. Adjusted Operating Margin: 23.6%. Adjusted EPS: $1.26, $0.03 above the midpoint of guidance. R&D Investment: Up 7.7%, 100 basis points ahead of revenue growth. Fiscal Year '26 Organic Revenue Growth Guidance: Approximately 5%. Fiscal Year '26 EPS Guidance: Raised to $5.60 to $5.66. Warning! GuruFocus has detected 7 Warning Signs with ODFJF. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Medtronic PLC (NYSE:MDT) reported consistent mid-single-digit revenue growth, with EPS exceeding guidance. The cardiovascular segment showed strong performance, with nearly 50% growth in cardiac ablation solutions driven by innovative product rollouts. The company raised its EPS guidance for the full year, reflecting confidence in continued financial acceleration. Medtronic PLC (NYSE:MDT) is poised for growth in the second half of the fiscal year, with several product launches and market expansions planned. The planned separation of the diabetes business is expected to be EPS accretive and improve operating margins, enhancing shareholder value. Negative Points Neuroscience growth was below trend due to specialty therapies, though improvements are expected in subsequent quarters. The Medsurge segment grew only 2%, aligning with expectations but indicating slower growth compared to other segments. The diabetes segment faced challenges in the US market, with growth primarily driven by international sales. Gross margin decreased by 80 basis points year-over-year, impacted by business mix and manufacturing ramp-up costs. Tariffs are expected to have a negative impact of approximately $185 million for fiscal '26, though this is an improvement from previous estimates. Q & A Highlights Q: Can you provide an update on the CAS business and its impact on overall growth? A: Geoff Martha, CEO, explained that the CAS business is accelerating, with 72% growth in the US. The company is confident in its ability to accelerate growth over FY26, with new technologies and a strong pipeline expected to have an outsized impact on US growth. Thierry Pieton, CFO, added that the US growth was impacted by slower growth in certain areas, but expects improvement as new products ramp up. Q: What is the purpose of the new Board committees focused on growth and operations? A: Geoff Martha, CEO, stated that the committees will provide focus and support management, particularly in growth and operational performance. The committees will include new directors with deep medtech experience and will have more frequent interactions with management to drive focus and execution. Q: Is the $2 billion target for annual CAS sales achievable in fiscal '26? A: Geoff Martha, CEO, confirmed that the target of an additional $1 billion on top of the FY25 base is on track. While it might extend into FY27, the company is confident in achieving this near-term goal. Q: How will the new directors and committees impact capital allocation and EPS growth? A: Geoff Martha, CEO, emphasized that the company is entering a new chapter focused on value creation. This includes more M&A, portfolio optimization, and increased investment in growth drivers. The committees will help ensure these strategies are executed effectively. Q: Can you discuss the potential impact of renal denervation on Medtronic's growth profile? A: Geoff Martha, CEO, highlighted that renal denervation (RDN) is a significant growth opportunity, with a massive patient population. The company is investing in market development and expects RDN to be a major driver of growth, potentially becoming one of the largest product categories for Medtronic. Q: What is the status of the diabetes business separation and its impact on growth? A: Thierry Pieton, CFO, confirmed that the separation is on track, with completion expected within 15 months. The diabetes business is entering a strong innovation cycle, and the separation is expected to be a value-creating event for shareholders. Q: How is the Hugo robotic system performing in international markets, and what are the expectations for the US launch? A: Michael Marinaro, EVP, stated that Hugo is performing well in over 30 countries, with significant double-digit growth in current accounts. The system's modular design and partnership approach are key strengths. The company is preparing for the US launch, with FDA approval processes underway. Q: What are the growth prospects for Medtronic's slower-growing businesses? A: Geoff Martha, CEO, noted that several slower-growing businesses have specific growth accelerators, such as new products and market expansions. The company is focused on driving growth across all segments, with organic and inorganic strategies. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store